CKLF like MARVEL transmembrane domain-containing 4

CMTM4
Identifiers
AliasesCMTM4, CKLFSF4, CKLF like MARVEL transmembrane domain containing 4
External IDsOMIM: 607887; MGI: 2142888; GeneCards: CMTM4
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez

146223

97487

Ensembl

ENSG00000183723

ENSMUSG00000096188

UniProt

Q8IZR5

Q8CJ61

RefSeq (mRNA)

NM_178818
NM_181521

NM_153582

RefSeq (protein)

NP_848933
NP_852662

NP_705810

Location (UCSC)Chr 16: 66.61 – 66.7 MbChr 8: 105.07 – 105.12 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse
CKLF-like MARVEL transmembrane domain-containing protein 4
Identifiers
SymbolCMTM4
Alt. symbolsCKLFSF4
Alt. namesChemokine-like factor superfamily member 4
HGNC19175
OMIM607887
RefSeqNM_178818.3
UniProtQ8IZR5
Other data
LocusChr. 16 q21-q22.1
Search for
StructuresSwiss-model
DomainsInterPro

CKLF like MARVEL transmembrane domain-containing 4 (i.e. CMTM4), formerly termed chemokine-like factor superfamily 4 (i.e. CKLFSF4), is a small transmembrane protein which passes the plasma membrane four times. It has 3 known isoforms, the CMTM4-v1 to CMTM4-v3 proteins. Protein isoforms are variant products that are made by alternative splicing of a single gene. The gene for the CMTM4 isoforms is located in band 22 on the long (i.e. "q") arm of chromosome 16. The CMTM4 gene and its 3 isoform proteins belong to the CKLF-like MARVEL transmembrane domain-containing family of structurally and functionally related genes and proteins. CMTM4-v1 and CMTM4-v2 are widely expressed in multiple human tissue while CMTM4-v3 has been detected only in the kidney and placental tissues.

The Cancer Genome Atlas indicates that CMTM4 protein is frequently reduced in colorectal cancer and its high expression is associated with increased overall survival rates in individuals with this cancer. CMTM4 protein was also found to be greatly reduced in the tissues of clear cell renal cell carcinoma compared to nearby normal renal (i.e. kidney) tissues and the forced overexpression of this protein in 786-O cells (a renal cancer cell line) inhibited their growth in culture as well as in a xenograph nude mouse model. Finally, CMTM4 protein levels were lower in several brain cancers, such as glioblastomas, neuroblastomas, and medulloblastomas, compared to their levels in nearby normal, non-tumorous brain tissues. These studies suggest CMTM4 may act to suppress these malignancies. Further studies are needed to confirm these relationships and determine if CMTM4 protein can be used as a marker for the severity of these malignancies and/or serve as a therapeutic target for treating them.